Carter Jennifer L. insider trades
Carter Jennifer L. has filed 4 Form 4s with the SEC that we hold, for CMAX (Director) and Insight Molecular Diagnostics Inc. (OCX) (Director). Across all of them we count 1 purchase worth $10.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 10,500 shares of Insight Molecular Diagnostics Inc. worth $10.0K, dated 2022-08-16. The first filing on our record is dated 2021-11-02 and the latest 2022-08-17.
CMAX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Insight Molecular Diagnostics Inc. (OCX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-08-16 | P, purchase reported on Form 4 | 10,500 | $10.0K | 2022-08-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1806505) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms